HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Interpharm Holdings, Inc. (Amex: IPA) (“Interpharm”), a manufacturer and distributor of generic pharmaceutical products, announced today that it has notified the American Stock Exchange (the “AMEX”) that it intends to voluntarily withdraw its common stock, $0.01 par value (the “Common Stock”), from the AMEX listing and from the registration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Act”) because of liquidity issues which have caused Interpharm not to meet listing standards of the AMEX. Interpharm is currently in the process of selling all of its assets to a third party. Interpharm has not arranged for listing or registration on another national securities exchange or for quotation of the Common Stock in a quotation medium (as defined in Rule 15c2-11 under the Act).
